Why Is ASTRANA HEALTH INC (ASTH) Stock Moving Today?

Astrana Health Inc (ASTH) shares rose 7.14% to $40.49 in today's session driven by strong earnings results and updated guidance. The stock opened at $37.69 and climbed steadily throughout the day, reaching a high of $40.61. The move follows the release of Q2 2026 earnings, which showed revenue rising 49% to $972.5 million and adjusted earnings per share hitting a record $0.80. The company also affirmed its full-year revenue guidance and exceeded expectations in its quarterly sales forecast.

What Happened

The earnings report highlighted a 58.9% year-to-date revenue increase and a net margin of 1.1%. Astrana Health reaffirmed its FY2026 revenue guidance of $3.8 billion to $4.1 billion, aligning closely with the $4.001 billion estimate. The company also raised its Q3 sales forecast to a range of $1.0 billion to $1.03 billion, slightly above the $1.021 billion estimate. These updates were accompanied by positive analyst actions, as Truist Securities and Barclays both raised their price targets to $55 and $53 respectively, maintaining their Buy and Overweight ratings. The stock closed the session at $40.49, with 0.2 million shares traded, representing 0.3 times the 3-month daily average.

What The Data Shows

Intraday trading showed a steady upward trajectory, with the stock reaching a new 52-week high on August 14. The current price of $40.49 sits within the 52-week range of $18.08 to $51.60. The stock has a market cap of $1.5 billion, a P/E ratio of 43.1, and a beta of 0.90. Recent congressional trades include a purchase by Donald J. Trump on March 30 and a sale on February 26. These transactions were disclosed in filings up to May 13.

What To Watch

Astrana Health will report Q2 2026 earnings in full during its scheduled earnings call. Investors should monitor coverage breadth and analyst commentary in the coming days for further insights.

Why is ASTH stock moving today?

ASTRANA HEALTH INC (ASTH) is drawing unusual attention today. Our newswire has captured 2 stories on ASTH across 2 sources in the last 36 hours, with AI sentiment reading bearish (avg 33/100). The most recent driver: "Astrana Health falls amid short call from GlassHouse Research" (Seeking Alpha).

Is ASTH a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of ASTH coverage reads 33/100 over 2 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.